BioSpace News Archive

Theranica announced today it has teamed up with Point32Health, the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, to conduct a 12-month pilot aimed at treating the organization’s commercial members suffering from episodic and chronic migraine.

Sebela Pharmaceuticals, a US pharmaceutical company with a market leading position in gastroenterology and a focus on innovation in women’s health, today announced the appointment of Victor Parker to the position of Chief Commercial Officer.

Health Union, the leader in social health, has been accepted to present research about irritable bowel syndrome symptom control, relationships with healthcare professionals and perceived quality of care at the 2022 Annual Scientific Meeting of the American College of Gastroenterology, also known as ACG 2022.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx” or “Company”) is reporting today that its U.S. joint venture (JV) partner and licensee, HLB Therapeutics (HLBT), has announced that it submitted a request for the Special Protocol Assessment (SPA) to the U.S. FDA for an in-depth discussion and assessment of the clinical protocol for a fourth phase 3 clinical trial (ARISE-4) for the treatment of dry eye disease.

GC LabTech, a subsidiary of GC Biopharma of South Korea, and a CAP & ISO accredited, FDA-registered specialty laboratory with life-saving plasma tests, selects 1health.io, an industry-leading software company revolutionizing the way laboratories expand testing into the at-home markets, to deliver its innovative new lab tests direct-to-consumers.

PharmaJet® announced they received a multi-year, $1.5 million grant from the United States Agency for International Development, to evaluate the impact of intradermal vaccine administration using their Tropis® Needle-free Injection System.

This month, North Carolina State University and TruDiagnostic take the next step in their investigation into the human imprintome with an exclusive license agreement to any diagnostic techniques utilizing imprintome control regions.

Brainlab, a digital medical technology company, and the German Society for Orthopedics and Orthopedic Surgery (DGOOC) will work together in the field of data privacy-compliant registry solutions.

Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has been named a finalist in the 2022 Fierce Healthcare Innovation Awards for its Cardea SOLO™ ECG System.

V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized, double-blinded, sham-controlled, multi-center pivotal clinical trial.